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Objective: Growth factors demonstrate mixed results improving wound healing.
Amnion-derived multipotent cells release physiologic levels of growth factors and tis-
sue inhibitors of metalloproteinases. This solution was tested in models of acute and
chronic wound healing. Methods: Acute model: Sprague-Dawley rats underwent la-
parotomy incisions. The midline fascia was primed with phosphate-buffered saline,
unconditioned media, or amnion-derived cellular cytokine suspension prior to incision.
Breaking strength of laparotomy wounds was tested with an Instron tensiometer. Inci-
sional hernia formation was measured after 28 days. Chronic model: Chronic, infected
granulating wounds were produced in rats by excising full thickness burn eschars inoc-
ulated with Escherica coli. Granulating wounds were treated with unconditioned media
oramnion-derivedcellularcytokinesuspension.Treatmentswereappliedeitheronday0
andday7orday0andtheneveryotherday.Woundsweretracedevery72hoursandbiop-
sied for quantitative bacteriology. Results: Acute model: Priming with amnion-derived
cellular cytokine suspension increased the breaking strength of laparotomy incisions in
comparison with phosphate-buffered saline or unconditioned media (P <. 05). Acute
wound failure and incisional hernia formation was 100% in the phosphate-buffered
saline and unconditioned media groups and 18% in the amnion-derived cellular cy-
tokine suspension–treated group (P <. 05). Chronic model: The rate of wound closure
wasacceleratedinamnion-derivedcellularcytokinesuspension–treatedchronicwounds
(P <. 05). Multidosing improved the effect. Conclusions: A physiologic solution of cy-
tokines and tissue inhibitors of metalloproteinases improves healing in models of acute
and chronic wounds. Such a cocktail can be produced from amnion-derived multipotent
progenitor cells.
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Stem cells or stem cell–like multipotent cells have great potential in the wound heal-
ing/tissue repair arena. They have the ability to differentiate into the various cell types of
the repair process and to secrete the humoral messengers necessary to mediate the cellular
processes.1−3 Adult stem-like cells derived from amnion have been shown to secrete many
cytokines and growth factors.4−6
Amnion-derivedmultipotentprogenitor(AMP)cellswererecentlyreportedtoincrease
the rate of gain of incisional breaking strength and decrease the incidence and severity of
acutewoundfailure.7 Itwaspostulatedthatoneofthepossiblemechanismsfortheimprove-
ment of acute wound healing in these experiments was that the AMP cells could be making
the necessary cytokine cocktail at the proper time and dose to affect a trajectory shift.7 The
secreted cytokines from AMP cells, amnion-derived cellular cytokine solution (ACCS),
have been studied using qualitative antibody arrays, enzyme-linked immunosorbent assays,
multiplex, and mass spectroscopy. The solution was found to contain a combination of cy-
tokines and growth factors at physiological levels.8 There was a good correlation between
the available levels of cytokines reported as measured in humans in normal and diseased
states and the level of cytokines found to be secreted by the AMP cells. In most cases,
cytokine and growth factor concentrations measured in ACCS were near the lower end of
reported physiological ranges. The exception was for tissue inhibitor of metalloproteinase-
1 (TIMP-1) and tissue inhibitor of metalloproteinase-2 (TIMP-2), which were detected in
ACCS at the upper limit of known physiological levels.
The purpose of the present study was to evaluate the effects of local application of
ACCS in both acute and chronic wound healing models.
MATERIALS AND METHODS
AMPcellsweregrowntoconfluency,andusingproprietarytechniques,thesupernatantwas
harvested.8 This secreted product, labeled ACCS, was then used in both the acute wound
model and the chronic wound model. Detailed analysis of the secreted growth factor and
cytokine profile, including, but not limited to, platelet-derived growth factor-BB, vascular
endothelial growth factor, angiogenin, TIMP-1, and TIMP-2 were previously reported.8
Acute wound model
Animal model
Theratmodelsoflaparotomywoundhealing(W)andincisionalhernias(H)werepreviously
reported.9,10 Sprague-Dawley rats (Harlan Inc, Indianapolis, Ind) weighing 450 to 500 g
were acclimated and housed under standard conditions. Animals were allowed ad libitum
intake of standard rat chow and water throughout the study. All animal care and operative
procedures were performed in accordance with the United States Public Health Service
GuidefortheCareofLaboratoryAnimals11 andwereapprovedbytheUniversityCommittee
on Use and Care of Animals of the University of Michigan.
Laparotomy wound healing model
Briefly, a 6 × 3 cm ventral full-thickness skin flap is raised through the avascular prefascial
plane, and a 5-cm full-thickness laparotomy incision is made through the linea alba at the
musculo-tendinous layer of the abdominal wall. The laparotomy wound is repaired with a
189ePlasty VOLUME 8
running 4-0 polypropylene suture, using 0.3-cm suture bites and 0.5-cm progress between
stitches. The suture is tied to itself at the end of the wound. The skin flap is sutured in place
with three 4-0 polypropylene stitches and steel wound clips. After 30 minutes of recovery
under a heat lamp, the rats are returned to fresh individual cages.
Three laparotomy wound groups were studied: (1) a phosphate-buffered saline–
treated wound (PBS-W); (2) an unconditioned media–treated wound (UCM-W); and (3)
an ACCS-treated wound (ACCS-W).8 In all 3 groups, the midline of the abdominal wall
(linea alba) was injected for a length of 5 cm with 200 μL of PBS, UCM, or ACCS. This
surgical site priming was achieved with a 22-gauge hypodermic needle (0.7 × 38 mm) into
the linea alba, as previously reported.7 Soft tissue distribution of PBS, UCM, or ACCS
suspension was achieved. After 5 minutes, the laparotomy incision was made and repaired
as described above.
On postoperative day (POD) 7, POD 14, and POD 28, the rats were killed. Isolated
abdominal wall muscle and tendon strips and fresh biopsies of the abdominal wall to la-
parotomy wound-healing interface were collected for mechanical and histological testing.
Laparotomy wound breaking strength and mechanical properties
Mechanical testing was performed on abdominal wall strips collected from the laparotomy
wound healing model as previously reported.10,12,13 All sutures were removed. Abdominal
wall strips were cut perpendicular to the wound-healing interface. A cutting template was
used to mark the abdominal wall to minimize size variability between specimens. Strips
werecut10mminwidthand60to80mminlength.Twostripswerecollectedfromeachrat
and testing was performed within 6 hours of necropsy. The fascial tissue strip thickness at
the wound and the length between grips were measured with Digimatic calipers (Mitutoyo
America Corp, Chicago, Ill). Stretch loading facilitated mechanical characterization of
the wound-healing interface. Force extension curves were generated for each fascial strip
with the use of an Instron Tensiometer (model 5542; Instron Corporation, Canton, Mass)
equipped with a 50-N static load cell set at a crosshead speed of 10 mm/min. The fascial
strips were mounted into the load frame with the use of pneumatic grips, preloaded to 0.1 N
with the gauge length measured between the grips that was around 10 mm. The load frame
applied testing loads to the fascial strips until mechanical tissue disruption occurred. The
anatomic location of the break was noted for each specimen. Force and tissue deformation
data were simultaneously recorded and captured on a computer connected to the load frame
viaadigitalinterfacecard.DataanalysiswasperformedwiththeuseoftheMerlinmaterials
testingsoftwarepackage(InstronCorporation)fromwhichbreakingstrength,themaximum
loadforce(Fmax)atmechanicalfailure(innewton)andtensilestrength,themaximumstress
developed in the specimen per unit area, calculated as Fmax/cross-sectional area (/newton
per square millimeter). Failure of the specimen was defined at the yield point rather than at
the point of ultimate tissue disruption because the yield point indicates the region where the
tissues are irreversibly deformed and mechanical defects first occur (ie, beyond the elastic
limit of the tissues).
Incisional hernia model
Mechanically,failinglaparotomyincisionsformincisionalhernias.Clinically,thismanifests
as defects in the musculo-tendinous-peritoneal layer of the abdominal wall. The serious
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clinical consequences of this are acute abdominal wall dehiscence and evisceration, the
incarceration and obstruction of peritoneal viscera, loss of the ability of the abdominal wall
to maintain torso posture, and chronic pain.
The incisional hernia models were used as previously reported.9,10 Briefly, a 6 × 3c m
ventral full-thickness skin flap was raised through the avascular prefascial plane. In each
experimental group, 200 μL of PBS, UCM, or ACCS was injected along the midline for
5 cm prior to laparotomy incision, infiltrating the linea alba. Next, a 5-cm full-thickness
laparotomy incision was made through the linea alba. Two 5-0 fast absorbing plain catgut
stitches were placed at the cranial end and mid-point of the laparotomy incision. The skin
flapwasreturnedandsuturedinplacewiththree4-0polypropylenesuturesandsteelwound
clips. The 3 experimental groups were (1) phosphate-buffered saline–primed hernia (PBS-
H); (2) UCM-primed hernia (UCM-H); and (3) ACCS-primed hernia (ACCS-H). On POD
28,theratswerekilledandthemusculo-tendinouslayeroftheabdominalwallwascollected
and examined for mechanical wound failure and incisional hernias.
Measurement of hernia size
For hernia size measurement, the hernia model rats were killed on POD 28. The skin was
dissected free circumferentially, and 5 ×10 cm of the abdominal wall muscle was excised.
The muscle was stretched out and pinned down on a dissecting board at the 4 corners
with the peritoneal side up. A ruler was set alongside the wound as a reference for every
sample. A standardized digital picture was then taken. Software Spot, Windows version
4.5 (Diagnostic Instruments, Inc., University of New South Wales, Sydney, Australia) was
used to calculate the hernia size on digital pictures. Calibration was set up using the rule
reference on each picture. A circle was drawn along the hernia ring to measure the hernia
size as square centimeter, as previously reported.7
Wound and tissue histology
Sagittal fascial laparotomy wound and/or hernia sections were then cut and immediately
fixed in 10% neutral-buffered formalin in preparation for histologic analysis. Specimens
were embedded in paraffin and sectioned and stained with hematoxylin and eosin or
trichrome by a core research histology service or the Immunoperoxidase Laboratory in
the University of Michigan Comprehensive Cancer Center.
Chronic wound model
Animal model
Chronic granulating wounds were prepared as previously described14−16 after approval
of the protocol by the Institutional Animal Care and Use Committee of the Bay Pines
Veterans Administration Medical Centre. This model has been histologically compared to
the human chronic granulating wound.17 Forty male Sprague-Dawley rats weighing 300 to
350 g were acclimatized for 1 week in the animal facility prior to use. Under intraperitoneal
pentobarbital (Nembutal) anesthesia, the rat dorsum was shaved and depilated. A full-
thickness dorsal burn measuring 30 cm2 was created by immersion in actively boiling
water.14,17 SevenmillilitersofRinger’slactatesolutionbysubcutaneousinjectionwasgiven
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to each rat to prevent dehydration. The wounds were treated in the group treatment scheme
as follows:
 Group I received no other treatment and served as the uninfected control.
 Group II received no other treatment and served as the infected control.
 Group III was treated with ACCS on the day of escharectomy and 7 days later.
 Group IV was treated with ACCS on day of escharectomy and then every other day.
 Group V was treated with unconditioned media on day of escharectomy and 7 days later.
Rats in the contaminated groups (groups II–V) were seeded with 5 × 108 colony
forming units (CFUs)/mL Escherichia coli (ATCC 25922) after they had been allowed to
cool for 15 minutes. Group I rats were not inoculated and served as the uninfected controls.
Bacteria were obtained from fresh 18-hour broth cultures and inoculum size was confirmed
by backplating. The animals were divided into 5 equal groups of 8 for different treatments
after the day 5 escharectomies.
Animals were individually caged and given food and water ad libitum. Five days
after burning, the eschars were excised from anesthetized animals, resulting in a chronic
granulating wound. These wounds contained greater than 105 bacteria/g of tissue (except
for those in group I). Histologic characterization of this wound with comparison to a human
granulating wound has previously been performed.17
Every 72 hours, animals were pretreated with buprinorphine (Buprenex) (0.1 mg/kg),
anesthetized with halothane inhalation, and the outlines of the wounds were traced onto
acetatesheets.Areacalculationswereperformedusingdigitalplanimetry.Anydriedexudate
that formed was atraumatically removed prior to any wound tracings or biopsies. Care was
taken to record only the advancing full-thickness margin rather than any advancing edge
of epithelium. This avoided the small component of advancement provided by the smooth,
pink, translucent, and hairless neoepithelium.16 Serial area measurements were plotted
against time. Biopsies for quantitative and qualitative bacterial analyses according to the
method of Heggers18 were performed on days 8, 17, and 28 postescharectomy to exclude
superinfection and to confirm bacterial levels in infected animals.
Statistics
Acute model
StatisticalanalysiswasperformedusingGraphPadPrismversion4.00forWindows(Graph-
PadSoftware,SanDiego,Calif,www.graphpad.com).t Testwasusedtocomparethediffer-
ence between the normal saline (NS) control group and the UCM- or ACCS-treated groups.
This software was also used to create the incidence curves of incisional hernia at POD 28
for fractional hernia at any particular hernia or wound defect size and compare the curves
among NS-H, UCM-H, and ACCS-H groups. Significant level was set at P < .05.
Chronic model
Foreachanimal’sdata,aGompertzequationwasfitted(typicalr2=0.85).19Usingthiscurve,
the wound half-life was estimated. Comparison between groups was performed using life
tableanalysisandtheWilcoxonranksumtest.Thestatisticalanalyseswereperformedusing
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SAS/STAT User’s Guide for Personal Computer20 and BMDP Statistical Software Manual21
packages on a personal computer. From the best-fit curves for the individual wounds, the
number of days required for 25%, 50%, and 75% healing of the original wounds were
calculated.19
RESULTS
Acute wound model
ACCS accelerates wound healing in laparotomy incisions
The abdominal wall was treated with ACCS to measure its effect on laparotomy wound
healing. Tensiometric analysis was performed on uniform abdominal wall strips with the
line of tissue deformation directly perpendicular to the linea alba/incision line. Tensiomet-
ric measurements found significant differences in the mechanical properties of the wound
among groups treated with the PBS-W, UCM-W, and ACCS-W. All wounds always me-
chanically disrupted at the fascial-fascial wound interface. Priming with ACCS accelerated
thegainofbreakingstrengthoflaparotomyincisionsincomparisonwithPBSorUCM(P<
.05). As shown in Figure 1, wounds treated with 200 μL of ACCS per rat developed greater
breaking strength by POD 7 in comparison to the PBS-W and UCM-W control groups.
Tensile strength was also greater in the ACCS-W group on POD 7, suggesting a physiolog-
ical effect on laparotomy wound scar quality (Fig 2). Wound samples harvested on POD
7 demonstrated more granulation tissue and organized fibro-proliferation with increased
angiogenesis in the ACCS-W group than PBS-W or UCM-W groups (Fig 3).
Figure 1. Tensiometric measurements of healing laparotomy inci-
sions. Fascial wound breaking strength was measured with a cali-
brated Instron Tensiometer on postoperative day 7. Values are the
mean ± SEM of 6 wound biopsies each from the phosphate-buffered
saline–treated wound (PBS-W) and unconditioned media–treated
wound (UCM-W) controls and the amnion-derived cellular cytokine
suspension–treated wound (ACCS-W) groups. Analysis of variance
was applied to measure the differences between the 3 groups. The
asterisk indicates significance at P < .05.
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Figure 2. Tensiometric measurements of healing laparotomy inci-
sions. Fascial wound tensile strength was measured with a calibrated
Instron Tensiometer on postoperative day 7. Values are the mean ±
SEM of 6 wound biopsies each from the phosphate-buffered
saline–treated wound (PBS-W) and unconditioned media–treated
wound (UCM-W) controls and the amnion-derived cellular cytokine
suspension–treated wound (ACCS-W) groups. Analysis of variance
was applied to measure the differences between the 3 groups. The
asterisk indicates significance at P < .05.
Figure 3. Morphology of fascial laparotomy wounds on postoperative day 7 (un-
conditioned media–treated wound [UCM-W] and amnion-derived cellular cytokine
suspension–treated wound [ACCS-W] shown). Trichrome staining was performed for
histology.ACCS-treatedwoundsdevelopedmoregranulationtissueandorganizedfibro-
proliferation than UCM-W groups. RM indicates rectus muscle and W, laparotomy
wound.
ACCS reduces laparotomy dehiscence and hernia formation
On POD 28, the rate of acute wound failure leading to incisional hernia formation was
100% in the PBS-H and UCM-H groups and 18% in the ACCS-treated group (P < .05). In
this model of intentional incisional hernia, the expected rate of incisional hernia formation
is 80% to 100%.9,10,12 Clinically, incisional hernia of the laparotomy incision is a very
common complication of the human abdominal wall. Clinical and experimental evidence
supportthattheprimarymechanismforincisionalherniaformationisveryearlymechanical
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Figure 4. Measurement of hernia size. Digital pictures were
taken with a ruler as reference for every wound sample. Software
spot was employed to measure the calibrated wound defect and
hernia sizes. A digital perimeter was drawn along the wound and
hernia ring to calculate the area in square millimeters. Analysis
of variance was applied to measure the differences between the
3 groups. The asterisk indicates significance at P < .05. PBS-H
indicates phosphate-buffered saline–primed hernia; UCM-H, un-
conditionedmedia–primedhernia;andACCS-H,amnion-derived
cellular cytokine suspension–primed hernia.
failure of the laparotomy wound.9,13 These studies have shown that there is a minimum me-
chanical wound failure size that predicts clinical incisional hernia formation with nearly
100% accuracy. In the human study, a fascial gap of 12 mm predicted incisional hernia
formation 94% of the time, whereas mechanical gaps of less than 12 mm healed 99.2% of
the time22 The conclusion is that small laparotomy defects do not form incisional hernias,
but bigger ones do. In the current study, rats were killed on POD 28 and the abdominal
wall was collected to measure directly laparotomy wound defect size and hernia formation.
As shown in Figure 4, laparotomy wound defect size in the ACCS-H group was signifi-
cantly smaller than those in the PBS-H or UCM-H groups (21 ± 4.3 mm2 versus 117 ±
11 mm2 versus 335 ± 23 mm2, respectively). Predictably, the incidence of incisional her-
nia formation was therefore also less in the ACCS-treated group (Fig 5). ACCS treatment
thereforereducestheincidenceoflaparotomywoundfailurethatprogressestoanincisional
hernia.
Chronic wound model
The rate of wound closure was statistically accelerated in ACCS-treated chronic infected
granulating wounds in comparison with the infected controls (P < .05). Applying ACCS
more frequently further accelerated the healing (Fig 6). The bacterial bioburden in the
wounds did not significantly change with ACCS treatment, remaining greater than greater
than 105 CFUs/g of tissue in groups II to V . This confirmed that the effect of ACCS was
not because of antimicrobial action.
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Figure 5. Amnion-derived cellular cytokine suspension treat-
ment reduces the incidence and severity of laparotomy wound
failure that progresses to an incisional hernia. The asterisk in-
dicates significance at P < .05. PBS-H indicates phosphate-
bufferedsaline–primedhernia;UCM-H,unconditionedmedia–
primed hernia; and ACCS-H, amnion-derived cellular cytokine
suspension–primed hernia.
Figure 6. Chronicinfectedgranulatingwound.Amnion-derivedcellu-
lar cytokine suspension (ACCS) treatment, both when administered on
day 0 and day 7 or every other day, accelerated healing in comparison
withtheinfectedcontrol(P<.05).MorefrequentapplicationsofACCS
resulted in the most rapid decrease in wound size. Despite the presence
of greater than 105 CFUs/g of tissue in the amnion-derived cellular cy-
tokine suspension–treated groups (III, IV), the wounds healed at least
as rapidly as when no bacteria were present (group I). I indicates non-
infected group; II, infected control; III, ACCS administered on day 0
and day 7; IV , ACCS administered on Monday, Wednesday, and Friday;
and V , unconditioned medium.
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DISCUSSION
Exogenous application of cytokines and growth factors has been reported for many animal
models of both acute and chronic wounds.23 In almost all of these models, it has been
suggested that wound healing would be enhanced by topical application of these peptides.
Using the acute wound model employed in these studies, the effects of individual cytokines
and their ability to decrease acute wound failure have been demonstrated.12,24,25 Although
singlegrowthfactorshavebeensuccessfulinimprovinghealinginthismodel,normalwound
healingisaccompaniedbyacombinationofcytokinesandtheyoccurinacascade.8,26,27 By
using a combination of cytokines present in physiological levels, it appears that ACCS can
improvewoundhealing.Theconceptbehindplatelet-derivedwoundhealingfactorsreported
by Knighton et al28 was to deliver a natural combination of cytokines. Unfortunately, the
exact levels of cytokines present in platelet-derived wound healing factors were determined
by its dilution, were not clearly delineated, nor were they compared to physiological levels
of cytokines necessary for healing as has been done for ACCS.8 The purpose of the current
studywastoreportanearlyclinicalapplicationusinganimalmodels.Becausetheendpointis
woundhealing,thepossibleinhibitoryeffectofanisolatedgrowthfactororcytokinewasnot
measured.Thisisatheoreticalpossibility,buttestingapanelofindividualgrowthfactorsand
cytokines, and then all possible combinations to tease out unique symbiotic or antagonistic
effects would take a long time at great expense and may only yield uninterpretable data.
Our rationale was that conditioned media (ACCS) containing physiologic combinations of
naturallyoccurringgrowthfactorsderivedfromamnioncellswouldimprovewoundhealing.
By shifting the wound healing trajectory to the left and gaining incisional strength
more rapidly with ACCS treatment (Figs 1 and 2), the incidence of acute wound failure was
decreased (Fig 5). Not only was the incidence decreased, the size of the resultant hernias
when they did occur was smaller (Fig 4). Histologic sections suggest a more accelerated
repair with ACCS treatment (Fig 3).
The chronic infected granulating wound model has also been used to evaluate indi-
vidual cytokine growth factors including basic fibroblast growth factor,14,15 granulocyte-
macrophagecolony-stimulatingfactor,29IL-4,30andkeratinocytegrowthfactor-2.31Ineach
of these cases, large doses of the test proteins were required for an effect. It was postulated
thatthiswasbecauseofdestructionorneutralizationofthecytokinesbytissueandbacterial
matrixmetalloproteinases(MMPs).32 OnereasonthatACCSmayhavebeeneffectiveinthis
model in physiological doses of cytokines is because of high levels of TIMP-1 and TIMP-2,
known natural inhibitors to MMPs.8 These high levels of TIMPs improve the MMP/TIMP
ratio, which has been reported to improve healing in chronic wounds.33 Tissue bacterial
bioburden remained high (>105 CFUs/g of tissue) in both treated and control wounds.
FromthepreviousreportonAMPcellsintheacutewoundmodelandtheseobservations
of ACCS treatment in both acute and chronic wounds, it appears that AMP cells and their
secreted products in ACCS can form a novel platform technology for further investigation
in the wound healing arena.
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